Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,404 | 221,036 | 104,916 | 0 | 0 |
| Marketable Securities | 248,747 | 88,835 | 24,178 | 0 | 0 |
| TOTAL | $302,969 | $310,545 | $129,645 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 524 | 499 | 516 | N/A | N/A |
| Other Non-Current Assets | 0 | 201 | 975 | 0 | 0 |
| TOTAL | $524 | $700 | $1,491 | $N/A | $N/A |
| Total Assets | $303,493 | $311,245 | $131,136 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,816 | 1,621 | 1,580 | 0 | 0 |
| TOTAL | $6,739 | $4,851 | $4,342 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,739 | $4,851 | $4,342 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,262 | 49,254 | N/A | N/A | N/A |
| Common Shares | 5 | 5 | N/A | 0 | 0 |
| Retained earnings | -51,315 | -40,962 | -34,147 | 0 | 0 |
| Other shareholders' equity | -33 | -54 | 160,214 | 0 | 0 |
| TOTAL | $296,754 | $306,394 | $126,794 | $0 | $0 |
| Total Liabilities And Equity | $303,493 | $311,245 | $131,136 | $0 | $0 |